Skip to content

Osi Pharmaceuticals, Inc.

Country not established

Devices
1

What Osi Pharmaceuticals, Inc. makes

Osi Pharmaceuticals, Inc. manufactures the OSI TRANSPROBE-1, a medical device designed for transcutaneous electrical nerve stimulation (TENS) applications, likely used for pain management or neuromodulation.

The OSI TRANSPROBE-1 is classified as a Class U (Unclassified) device under FDA regulations and is listed under the FDA’s Premarket Approval (PMA) pathway. The company is based in the United States.

AI-generated from registry data, 19 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Osi Transprobe-1 Ref P880045

    Withdrawn Regimes: PMA, withdrawn Registry: PMA Class:—

Frequently asked questions

How many devices does Osi Pharmaceuticals, Inc. have in the registry?

The registry currently lists 1 device for Osi Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Osi Pharmaceuticals, Inc.'s devices?

Among its 1 most recently registered device, Osi Pharmaceuticals, Inc. has devices listed in FDA PMA (1 device).

What are the newest devices from Osi Pharmaceuticals, Inc. in the registry?

The most recently registered devices listed for Osi Pharmaceuticals, Inc. include OSI TRANSPROBE-1.

Generated automatically from registry data and not verified by a human reviewer.